Log in

Relevant bibliographies by topics / Deep vein thrombosis

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Deep vein thrombosis'

Author: Grafiati

Published: 4 June 2021

Last updated: 13 June 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Deep vein thrombosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Deep vein thrombosis"

1

Aziz, F., J. T. Chen, and A. J. Comerota. "Catheter-Directed Thrombolysis of Iliofemoral Deep Vein Thrombosis Reduces Deep Vein Thrombosis Recurrence." Journal of Vascular Surgery 53, no. 1 (2011): 252. http://dx.doi.org/10.1016/j.jvs.2010.11.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Parsi, Kurosh, Brydon Panozzo, Alison Bull, et al. "Deep vein sclerosis following sclerotherapy: Ultrasonic and d-dimer criteria." Phlebology: The Journal of Venous Disease 35, no. 5 (2019): 325–36. http://dx.doi.org/10.1177/0268355519873534.

Full text

Abstract:

Objectives The aim of sclerotherapy is to induce fibrosclerosis of superficial veins. We postulated that inadvertent entry of sclerosants into deep veins can result in sclerotic occlusion, deep vein sclerosis, a non-thrombotic process distinct from spontaneous deep vein thrombosis. The aim of this study was to assess the role of d-dimer in differentiating between deep vein sclerosis and deep vein thrombosis. Methods Proximal trunks of great and small saphenous veins were treated with endovenous laser ablation. Venous tributaries and perforators were treated with foam ultrasound guided sclerotherapy. Ultrasound studies of lower limb deep veins were performed before and one week after the procedures, to detect deep vein occlusions (DVOs). d-dimer levels were measured for DVOs and long-term ultrasound studies monitored the recanalisation rates. Results In a six-year period, 9143 procedures were performed in 1325 patients for bilateral varicose veins. This included 1124 endovenous laser ablation and 8019 foam ultrasound guided sclerotherapy procedures. A total of 259 DVOs (2.83%) were identified on ultrasound which included 251 deep vein sclerosis (2.74%), seven deep vein thrombosis (0.07%) and one endovenous heat-induced thrombosis (EHIT, 0.08%). d-dimer values <0.5 µg/mL excluded deep vein thrombosis s, 0.5–1.0 µg/mL were more likely to be associated with deep vein sclerosis and >1.0 µg/mL were a more likely to be associated with deep vein thrombosis. Lower sclerosant concentrations and higher foam volumes were associated with increased risk of DVO ( p < .0001). No significant relationship was found between DVO and gender or thrombophilia. Deep vein thrombosis and EHIT cases but not deep vein sclerosis patients were anticoagulated. None had thromboembolic complications. Patients were followed up for a median of 299 days (37–1994 days). Recanalisation rates were 71.1% for deep vein sclerosis (92.3% competent) and 71.4% for deep vein thrombosis (60.0% competent). Conclusions Deep vein sclerosis is a relatively benign clinical entity distinct from deep vein thrombosis and does not require anticoagulation. Majority of affected veins on long-term follow-up regain patency and competence. d-dimer can be used to assist in differentiating deep vein sclerosis from deep vein thrombosis.

APA, Harvard, Vancouver, ISO, and other styles

3

Gillet, JL, M. Lausecker, M. Sica, JM Guedes, and FA Allaert. "Is the treatment of the small saphenous veins with foam sclerotherapy at risk of deep vein thrombosis?" Phlebology: The Journal of Venous Disease 29, no. 9 (2013): 600–607. http://dx.doi.org/10.1177/0268355513497362.

Full text

Abstract:

Objective To assess the deep vein thrombosis risk of the treatment of the small saphenous veins depending on the anatomical pattern of the veins. Method A multicenter, prospective and controlled study was carried out in which small saphenous vein trunks were treated with ultrasound-guided foam sclerotherapy. The anatomical pattern (saphenopopliteal junction, perforators) was assessed by Duplex ultrasound before the treatment. All patients were systematically checked by Duplex ultrasound 8 to 30 days after the procedure to identify a potential deep vein thrombosis. Results Three hundred and thirty-one small saphenous veins were treated in 22 phlebology clinics. No proximal deep vein thrombosis occurred. Two (0.6%) medial gastrocnemius veins thrombosis occurred in symptomatic patients. Five medial gastrocnemius veins thrombosis and four cases of extension of the small saphenous vein sclerosis into the popliteal vein, which all occurred when the small saphenous vein connected directly into the popliteal vein, were identified by systematic Duplex ultrasound examination in asymptomatic patients. Medial gastrocnemius veins thrombosis were more frequent ( p = 0.02) in patients with medial gastrocnemius veins perforator. A common outlet or channel between the small saphenous vein and the medial gastrocnemius veins did not increase the risk of deep vein thrombosis. Conclusion Deep vein thrombosis after foam sclerotherapy of the small saphenous vein are very rare. Only 0.6% medial gastrocnemius veins thrombosis occurred in symptomatic patients. However, the anatomical pattern of the small saphenous vein should be taken into account and patients with medial gastrocnemius veins perforators and the small saphenous vein connected directly into the popliteal vein should be checked by Duplex ultrasound one or two weeks after the procedure. Recommendations based on our everyday practice and the findings of this study are suggested to prevent and treat deep vein thrombosis.

APA, Harvard, Vancouver, ISO, and other styles

4

Brandao, Gustavo Mucoucah Sampaio, Marcone Lima Sobreira, and Hamilton Almeida Rollo. "Recanalization after acute deep vein thrombosis." Jornal Vascular Brasileiro 12, no. 4 (2013): 296–302. http://dx.doi.org/10.1590/jvb.2013.050.

Full text

Abstract:

The process of recanalization of the veins of the lower limbs after an episode of acute deep venous thrombosis is part of the natural evolution of the remodeling of the venous thrombus in patients on anticoagulation with heparin and vitamin K inhibitors. This remodeling involves the complex process of adhesion of thrombus to the wall of the vein, the inflammatory response of the vessel wall leading to organization and subsequent contraction of the thrombus, neovascularization and spontaneous lysis of areas within the thrombus. The occurrence of spontaneous arterial flow in recanalized thrombosed veins has been described as secondary to neovascularization and is characterized by the development of flow patterns characteristic of arteriovenous fistulae that can be identified by color duplex scanning. In this review, we discuss some controversial aspects of the natural history of deep vein thrombosis to provide a better understanding of its course and its impact on venous disease.

APA, Harvard, Vancouver, ISO, and other styles

5

Kaufman, Brian S., and Christopher C. Young. "Deep Vein Thrombosis." Anesthesiology Clinics of North America 10, no. 4 (1992): 823–67. http://dx.doi.org/10.1016/s0889-8537(21)00009-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Jackson, Mike. "Deep vein thrombosis." Nursing Standard 28, no. 42 (2014): 61. http://dx.doi.org/10.7748/ns.28.42.61.s45.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Friera, Alfonsa, Nuria R. Giménez, Paloma Caballero, Pilar S. Moliní, and Carmen Suárez. "Deep Vein Thrombosis." American Journal of Roentgenology 178, no. 4 (2002): 1001–5. http://dx.doi.org/10.2214/ajr.178.4.1781001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Webber, Rachel. "Deep vein thrombosis." Inpharma Weekly &NA;, no. 929 (1994): 9–10. http://dx.doi.org/10.2165/00128413-199409290-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Emanuele, Patricia. "Deep Vein Thrombosis." AAOHN Journal 56, no. 9 (2008): 389–92. http://dx.doi.org/10.3928/08910162-20080901-02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tindale, Rabina. "Deep vein thrombosis." Emergency Nurse 12, no. 8 (2004): 8. http://dx.doi.org/10.7748/en.12.8.8.s14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Deep vein thrombosis"

1

Warwick, David John. "Deep vein thrombosis after total hip replacement." Thesis, University of Bristol, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.283969.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Howard, Adam Quentin. "The prevention of post-operative deep vein thrombosis." Thesis, Imperial College London, 2007. http://hdl.handle.net/10044/1/8187.

Full text

Abstract:

Background: In a university hospital, disparate and unsatisfactory thromboprophylaxis in surgical patients was found. No hospital consensus was in place for the prevention of postoperative deep vein thrombosis (DVT). Literature review suggested low molecular weight heparin (LMWH) and anti-embolic stockings were the best prophylaxis, however the optimal length of stocking was unknown. Method: Audit of thromboprophylaxis in surgical patients and surgical doctors was performed. A randomised controlled trial investigated the efficacy and safety of a new single protocol of LMWH and the best length of stocking, for every patient requiring surgery under general anaesthesia. Of 426 patients interviewed, 376 were randomised into three stocking groups, Medi Thrombexin® Climax™ thigh-length, Thrombexin® Climax™ knee-length and Kendall TEDTM thigh-length. All patients received LMWH. DVT incidence was assessed by duplex ultrasonography. Complications of thromboprophylaxis were recorded. Compliance and health outcome measures were developed to assess patient stocking acceptability. Results: Audit revealed inadequate surgical thromboprophylaxis. A simple 'single protocol' improved doctors' thromboprophylaxis compliance on replicate audit. The randomised trial assessing the 'single protocol' showed no postoperative DVT occurred in the low or moderate-risk patients (n=85). Twenty-one DVT occurred in nineteen patients, all were high-risk patients (n=291): two with Thrombexin® Climax™ thigh-length stockings and eleven with Thrombexin® Climax™ kneelength (p<O.05). Six patients wearing TEDTM thigh-length stockings developed DVT. Groups were similar for age, gender, thromboembolic risk, surgical type and protocol compliance. One significant bleeding complication occurred. A validated health outcome measure showed patient satisfaction with knee-length stockings was significantly greater than with thigh-length. However, stocking compliance for in-patients was equal. Whereas patients' compliance with knee-length was significantly greater after hospital discharge. Conclusion: A single protocol employing LMWH and thigh-length stockings abolished DVT (diagnosed by duplex) in low and moderate-risk patients and reduced DVT to 2% in high-risk patients. The 'Blanket LMWH-thigh-length stocking protocol' was effective, safe and the length of stocking proved significant. A new single protocol and hospital consensus to prevent postoperative DVT was achieved.

APA, Harvard, Vancouver, ISO, and other styles

3

Baarslag, Hendrik Jan. "Diagnosis and management of upper extremity deep vein thrombosis." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2003. http://dare.uva.nl/document/86567.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Cate-Hoek, Arina Janna ten. "New developments in diagnosis and treatment of deep vein thrombosis." [Maastricht] : Maastricht : [Maastricht University] ; University Library, Universiteit Maastricht [host], 2008. http://arno.unimaas.nl/show.cgi?fid=13095.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Kahn, Susan Rebecca. "Clinical predictors of-deep vein thrombosis in patients with leg symptoms." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp04/mq29730.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Lindmarker, Per. "Treatment of deep vein thrombosis and risk of recurrent venous thromboembolism /." Stockholm, 1998. http://diss.kib.ki.se/1998/91-628-3211-5/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Kahn, Susan Rebecca. "Clinical predictors of deep vein thrombosis in patients with leg symptoms." Thesis, McGill University, 1996. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=27355.

Full text

Abstract:

Background. Deep vein thrombosis (DVT) is a common condition with significant mortality and morbidity. Proximal DVT is more often associated with pulmonary embolism and the post-phlebitic syndrome than calf DVT. Identifying which clinical variables predict DVT and proximal DVT could be useful for the effective targeting of diagnostic tests for DVT.<br>Purpose. To determine, in patients presenting with leg symptoms, which clinical variables best predict (1) DVT and (2) proximal DVT. To estimate the probability of DVT in an individual presenting with a particular grouping of these variables.<br>Results. Male sex, orthopedic surgery, and warmth and superficial venous dilation on exam were independent predictors of DVT (adjusted odds ratios and 95% confidence intervals 2.8 (1.5, 5.1), 5.4 (2.2, 13.6), 2.1 (1.2, 3.9) and 2.9 (1.4, 5.7), respectively) and proximal DVT (adjusted odds ratios 2.4 (1.2, 4.8), 4.1 (1.4, 12.3), 2.3 (1.2, 4.7) and 3.4 (1.6, 7.0), respectively). A clinical prediction index that categorized patients into different levels of DVT risk was created, and its ROC curve showed moderate predictive ability. No single cutoff point was ideal in terms of desired sensitivity and specificity, however the index was useful in a strategy aimed to limit the need for contrast venography in patients with suspected DVT. Using this strategy, 78% of study patients could have avoided contrast venography. (Abstract shortened by UMI.)

APA, Harvard, Vancouver, ISO, and other styles

8

Balendra, Padma Rani. "Deep vein thrombosis of the leg : natural history and haemostatic variables." Thesis, Queen's University Belfast, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.334477.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Brock, Sheila Anne. "Compression and Doppler ultrasound of deep vein thrombosis in patients on tuberculosis treatment." Thesis, Cape Peninsula University of Technology, 2013. http://hdl.handle.net/20.500.11838/1570.

Full text

Abstract:

Thesis submitted in fulfilment of the requirements for the degree of Doctor of Technology: Radiography in the Faculty of Health and Wellness Sciences at the Cape Peninsula University of Technology 2013<br>Background. Ultrasound has until recently been regarded as a sophisticated examination reserved for tertiary health care. In reality it is well suited to the district or primary health-care situation. A DVT (deep vein thrombosis) is an important complication of the treatment of TB and this can lead to more devastating sequelae such as a pulmonary embolus. Many DVTs are clinically silent, making the diagnosis difficult. Method. This study was a prospective, longitudinal observational study. The study documented the incidence of DVTs and their onset, assessed certain aspects in an attempt to identify some risk factors, and noted the most common position of the DVT in a TB population. The feasibility of a sonographer-led ultrasound clinic for the diagnosis of DVTs was also assessed. This was achieved by screening the in-patient population at a district TB hospital. The participants received up to four routine duplex Doppler compression ultrasound examinations of the venous system of the lower extremities on week 0, week 4, week 8 and week 14. In addition a single abdominal ultrasound was performed at week 0. Results The incidence of DVTs in this TB population was 15.3%. A median of day 10 from commencing TB treatment was identified as the most common day to develop a DVT. The popliteal vein was the most frequent position for a DVT. Several statistically significant factors were identified, including a decreased ambulatory status, TB regimen and the use of anticoagulants. Only 52% of the DVTs were clinically symptomatic. The clinical evaluation for a DVT diagnosis in this study population had a sensitivity of 52.4% and a specificity of 65.3%. The positive predictive value (PPV) was 21.7%. Of the abdominal ultrasound reports there were 75.5% (281) abnormal reports, 22.5% (n = 90) normal reports and 4.5% (n = 18) with no report. Conclusion This body of work has shown how an effective ultrasound service can be provided at a district level TB hospital successfully administered by a trained ultrasonographer. This also facilitated a screening service to diagnose both symptomatic and asymptomatic deep vein thromboses in newly diagnosed tuberculosis patients. This study confirmed a higher rate of DVT in newly diagnosed TB patients than has been previously seen. It also provided detail on additional risk factors. The study illustrates the poor performance of clinical signs and symptoms as a trigger for further investigation for the confirmation of a DVT. Given the frequency and impact of the embolic complications of DVT, this study provides a strong justification for further research into routine serial ultrasonic screening and/or prophylactic antithrombolytics in newly diagnosed TB patients. As well as the DVT ultrasound scans there was the ancillary service offered by the research sonographers. This included an abdominal scan that detected abdominal pathology in 75% of the scans performed. An ultrasound scan is not pathognomonic but it does provide significant insight into the extent of some of the abdominal pathologies seen in TB patients. The information provided from this study gives a good indication of the problem that DVTs present in this population and the complexities of the disease TB. It is hoped that the results from this study will better equip the medical team in the non-tertiary situation to be vigilant for the presence of a DVT and educate them on the usefulness of the ultrasound scan.

APA, Harvard, Vancouver, ISO, and other styles

10

Alshehri, Mohammed Faiez. "Risk factors for deep vein thrombosis in a South African public hospital." Master's thesis, University of Cape Town, 2013. http://hdl.handle.net/11427/2879.

Full text

Abstract:

Includes bibliographical references<br>Includes abstract.<br>The evidence suggests an association between HIV, TB and DVT. There are no studies of this link in the Southern African setting, where the incidence of both of these conditions (HIV and TB) is high. We therefore undertook a study to define the incidence of HIV and TB in patients with confirmed DVT in this setting. The aim of this study is to describe the incidence of HIV, TB and the more commonly accepted risk factors in patients with confirmed DVT in a South African public hospital.

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Deep vein thrombosis"

1

Autar, Ricky. Deep vein thrombosis: The silent killer. Quay Books, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Beek, Edwin J. R. van., Büller H. R, and Oudkerk Matthijs, eds. Deep vein thrombosis and pulmonary embolism. J. Wiley, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Griffin, Jane. Deep vein thrombosis and pulmonary embolism. Office of Health Economics, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

van Beek, Edwin J. R., Harry R. Bller, and Matthijs Oudkerk, eds. Deep Vein Thrombosis and Pulmonary Embolism. John Wiley & Sons, Ltd, 2009. http://dx.doi.org/10.1002/9780470745007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Raskin, Gregory Stephen. Bedside doppler identification of lower-extremity deep-vein thrombosis. s.n.], 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

F, Tapson Victor, and Ortel Thomas L. 1957-, eds. 100 questions & answers about deep vein thrombosis and pulmonary embolism. Jones and Bartlett Publishers, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Inc, ebrary, ed. Deep vein thrombosis and pulmonary embolism: A guide for practitioners. M&K Update Ltd., 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Parker, James N., and Philip M. Parker. Deep vein thrombosis: A medical dictionary, bibliography, and annotated research guide to Internet references. ICON Health Publications, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Autar, Atmaram. Nursing assessment of clients at risk of deep vein thrombosis (DVT): Developing the Autar DVT scale. University of Central England in Birmingham, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tinkler, Kerry. Setting up, piloting, implementing and reviewing a GP direct access service for the diagnosis of lower limb deep vein thrombosis. University of Portsmouth, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Deep vein thrombosis"

1

Bauersachs, Rupert M., and Bernd Krabbe. "Deep Vein Thrombosis." In PanVascular Medicine. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-37078-6_208.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mintz, Ari J., and Bruce L. Mintz. "Deep Vein Thrombosis." In Atlas of Clinical Vascular Medicine. Blackwell Publishing Ltd., 2013. http://dx.doi.org/10.1002/9781118618189.ch31.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Desai, Sapan S., Eric Mowatt-Larssen, and Ali Azizzadeh. "Deep Vein Thrombosis." In Phlebology, Vein Surgery and Ultrasonography. Springer International Publishing, 2013. http://dx.doi.org/10.1007/978-3-319-01812-6_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Coccheri, Sergio. "Deep vein thrombosis." In Developments in Cardiovascular Medicine. Springer Netherlands, 1996. http://dx.doi.org/10.1007/978-94-011-5406-2_28.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Harnarayan, Patrick, Dave Harnanan, and Vijay Naraynsingh. "DEEP Vein Thrombosis." In Approach to Lower Limb Oedema. Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-6206-5_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Bauersachs, Rupert M., and Bernd Krabbe. "Deep Vein Thrombosis." In PanVascular Medicine. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-37393-0_208-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Masterton-Smith, Charlotte, and Kevin O'Kane. "Deep vein thrombosis." In Acute Medicine - A Practical Guide to the Management of Medical Emergencies, 5th Edition. John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119389613.ch56.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Richter, E. I. "Acute Deep Vein Thrombosis." In Radiology of Peripheral Vascular Diseases. Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-56956-2_37.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Sandhu, A. S., D. Johns, and L. E. Albertyn. "Deep cerebral vein thrombosis." In Proceedings of the XIV Symposium Neuroradiologicum. Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-49329-4_78.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Theisler, Charles. "Deep Vein Thrombosis (DVT)." In Adjuvant Medical Care. CRC Press, 2022. http://dx.doi.org/10.1201/b22898-102.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Deep vein thrombosis"

1

Hussein, Emad A. "Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis: Predictors of Outcome." In PAIRS Annual Meeting. Thieme Medical and Scientific Publishers Pvt. Ltd., 2020. http://dx.doi.org/10.1055/s-0041-1729020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Gauchel, N., K. Naber, K. Wolf, et al. "Platelet Serotonin in Arterial and Deep Vein Thrombosis." In 63rd Annual Meeting of the Society of Thrombosis and Haemostasis Research. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1680274.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

"Tutorial II: Screening System for Deep Vein Thrombosis." In 2009 International Conference on Electrical, Communications, and Computers. IEEE, 2009. http://dx.doi.org/10.1109/conielecomp.2009.62.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Dhillon, Permesh Singh, Asim Shah, Thomas Hall, and Said Habib. "Postthrombotic Syndrome in Acute Iliofemoral Deep Vein Thrombosis." In PAIRS Annual Meeting. Thieme Medical and Scientific Publishers Pvt. Ltd., 2020. http://dx.doi.org/10.1055/s-0041-1729021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Widmer, L. K., M. Th Widmer, E. Zemp, et al. "LONG-TERM MORBIDITY AFTER DEEP VEIN THROMBOSIS (DVT)." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642969.

Full text

Abstract:

5 yr follow-up of 341 patients with special consideration of post-thrombotic syndrome (PTS) and methodolo-cigal difficulties.INTRODUCTIONMethodological difficulties responsable for lacking unité de doctrine: (a) Acute phase: random allocation taking into account DVT of different extent; assessment of effect of treatment (b) Follow-up: drop out definition of parameters of success esp. PTS, comparison of truely comparable groups, limited information about economic aspects.5 yr FOLLOW-UP PTS-INCIDENCE after ANTICOAGULATION (AC) or THROMBOLYSIS (TL)Method: 341 non-randomized, consecutive patients; unilateral DVT documented by initial and control-phlebo-gramm (<14 d) , treated by AC or thrombolytic agents. 226 men, 115 women, 51.9 ± 16 yr at entry. DVT: left 193, right 148; limited 35 %, extended 65 %. Treatment effect by analysis “vein per vein”. Re-examination: “blind technique” by 2 observers; definition of PTS considering corona phlebectatica, cyanosis, edema, cirumference difference, trophic changes; Score > 10= PTSResults:1. Group with unchanged initial and control phlebogrammCorrelation between DVT-extent at entry and PTS-incidence (table). Consequently comparison of AC and TL must be made between subgroups with similar DVT-extent at entry.2. Subgroups with clearance ( + ) vs. non-clearance ( - ):Figures white PTS without ulcera, black leg ulcer

APA, Harvard, Vancouver, ISO, and other styles

6

Prandoni, P., M. Vigo, M. V. Huisman, J. Jonker, H. R. Büller, and J. W. ten Cate. "COMPUTERIZED IMPEDANCE PLETHYSMOGRAPHY, A NEW PLETHYSMOGRAPHIC METHOD TO DETECT DEEP VEIN THROMBOSIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642893.

Full text

Abstract:

Since the clinical diagnosis of deep vein thrombosis (DVT) is unreliable, several invasive and non-invasive methods have been developed recently. Of these, impedance plethysmography (IPG) is a widely employed technique based on measurement of changes in blood volume produced by temporary obstruction. IPG has been shovn in large prospective studies in symptomatic patients to be a safe and effective alternative to contrast venography, if used either in combination with 1251-fibrinogen legscanning or serially as a single test. Currently available impedance plethysmographs are limited by several technical and operational problems. Therefore, a new computerized impedance plethysmograph (CIP) was developed, having the following characteristics: portability, battery operated and fully automated. A prospective two-center study in 299 consecutive outpatients was done to compare the efficacy of CIP vs. venography in patients with symptomatic DVT. Using a blind design i.e. care was taken to insure that CIP and venography were performed and interpreted independently. The results in patients without venography proven thrombosis and those with proximal vein thrombosis were subjected to a discriminant analysis producing a line of best discrimination between normal and proximal vein thrombosis. In 14 patients it was not possible to obtain an adequate CIP tracing. 12 patients were not entered because of refusal to undergo venography and 15 patients were excluded from analysis because of poor opacification of the proximal veins. On the basis of discriminant analysis 138 of the CIP results were classified as normal and 120 as abnormal. 175 patients were normal on venography and 83 had proximal thrombosis. The sensitivity of CIP for proximal vein thrombosis was thus 95% while the speci-+ ficity was 77%. It is concluded that computerized impedance plethysmography is a potentially sensitive method to detect proximal vein thrombosis in patients with clinically suspected deep vein thrombosis.

APA, Harvard, Vancouver, ISO, and other styles

7

Martin, M., and B. J. O. Fiebach. "SHORT-TERM LYSIS BY ULTRAHIGH STREPTOKINASE TREATMENT IN CHRONIC ARTERIAL OCCLUSIONS AND ACUTE DEEP VENOUS THROMBOSIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643035.

Full text

Abstract:

171 chronic arterial occlusions and 86 acute venous thromboses were treated by systemic ultrahigh streptokinase (UHSK) infusions. 38% of the patients were over 65, 27% over 70 years of age. The UHSK scheme consisted of a 1.5 million units SK per hour maintenance infusion over a period of 6 hours. 46% of the patients received one, 47% two, 6% three, and 1% four series (one series per day). 81% of the arterial patients had a history of less than 3 months. In 54% of the cases PTA followed UHSK treatment for dilation of a residual stenosis or removal of occlusion residues still persistent. In the venous patients the most proximal location was distributed as follows: calf veins 1%, femoral vein 57%, iliac vein 28%, subclavian vein 14%. The average thrombosis history was 8 days.Clearance rates of chronic arterial occlusionsBy setting up of sub-groups more favorable results were calculated. For exemple, a femoral occlusion group consisting of cases with a history shorter than 6 weeks and 2 or 3 calf arteries patent displayed a clearance rate of 77%, a figure much higher than the overall femoral resultClearance rates of deep venous thrombosisThe thrombosis duration played a significant role for thrombosis dissolution. The average occlusion history was 6 days in the total clearance group compared with 12 days in the unsuccessful cohort.

APA, Harvard, Vancouver, ISO, and other styles

8

Huisman, M. V., H. R. Buller, J. W. ten Cate, E. A. van Royen, and J. Vreeken. "SILENT PULMONARY EMBOLISM IN PATIENTS WITH DEEP VEIN THROMBOSIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642890.

Full text

Abstract:

In patients presenting with clinically suspected deep vein thrombosis symptomatic pulmonary embolism is rarely apparent. To assess the prevalence of asymptomatic pulmonary embolism in outpatients with proven deep vein thrombosis, perfusion ventilation lungscans were performed in 101 consecutive patients at the first day of treatment and after one week of therapy. Fifty-one percent of these patients had a high probability lung-scan at the start of treatment. In control patients (n=44) without deep venous thrombosis but referred through the same filter, the prevalence of high-proba-bility scans was only 5%. After one week of anticoagulant treatment complete to partial improvement was observed in 55% of the patients while in another 24% of the patients the scan remained normal.It is concluded that lungscan detected asymptomatic pulmonary embolism occurs frequently in patients presenting with symptomatic deep venous thrombosis and that the majority of these emboli resolve within one week of anticoagulant treatment.

APA, Harvard, Vancouver, ISO, and other styles

9

Powers, P. J., M. Gent, R. Jay, J. Hirsh, M. Levine, and G. Turpie. "DEEP VEIN THROMBOSIS PROPHYLAXIS IN SURGICALLY TREATED FRACTURED HIP PATIENTS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643692.

Full text

Abstract:

Deep vein thrombosis is a major complication in'patients treated surgically for fractured hip. Methods employed toreduce the risk of thrombosis include dextran, ASA, warfarin, low or adjusted dose heparin and calf compression, but none has widespread acceptance.A randomized trial wascarried out to assess the effectiveness of sodium warfarinand acetyl salicylic acid(aspirin) compared to placebo inthe prevention of venous thrombosis in fractured hip patients. One hundred and ninty four patients were randomizedto receive warfarin (65 patients), ASA (66 patients) or placebo (63 patients).Prophylaxis commenced post operatively and continued for 21 days or until discharge, if earlier.Warfarin patients received 10 mg sodium warfarin orally as soon as possible after surgery. Warfarin was then given daily according to the prothrombin time (PT), to obtain a PT of 16 seconds on the 5th post operative day. The PT was maintain at 16 to 18 seconds until the end of treatment.ASA and placebo patients received enteric coated tablets, 650 mg twice daily, in a double blind fashion beginning as soon as possible post operatively and continuingto the end of treatment. Surveillance testing and I-fibrinogen leg scanning and impedance plethysmography was performed and venography was done if either test suggested thrombus at the popliteal vein or above. Otherwise venography was performed at day 21 or prior to discharge, if earlier. Venous thrombosis occurred in 13 patients (20%) in the warfarin group, 27 patients (^0.9%) in the ASA group, and 29 patients (46%) in the placebo group (P=0.005). Proximal vein thrombosis or pulmonary embolism occurred in 6patients (9.2%) in the warfarin group,7 patients (10.6%) in the ASA and 19 patients (30.2%) in the placebo group (P=0.002). Two major hemorrhages occurred in the warfarin group, none in the ASA group, and 2 in the placebo group.The results of this study show sodium warfarin to be safeand effective in reducing thromboembolic complications infractured hip patients and ASA to be effective in reducing thrombosis involving the proximal deep veins of the lower limbs in these patients.

APA, Harvard, Vancouver, ISO, and other styles

10

Trübestein, G., M. Ludwig, M. Wilgalis, R. Trübestein, and S. Popov. "FIBRINOLYTIC THERAPY WITH STREPTOKINASE AND UROKINASE IN DEEP VEIN THROMBOSIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643001.

Full text

Abstract:

336 patients with acute 1-6 day old, and subacute, 1-3 week old deep vein thrombosis were treated with streptokinase (SK) or urokinase (UK) up to April 1, 1985. 175 patients were included in the SK group, 161 patients in the UK group. A standardized SK-heparin and the standardized UK-heparin dosage scheme with 100.000 IU SK/h or 100.000 IU UK/ h were used. In patients with acute deep vein thrombosis a complete recanalisation could be achieved in 67% and a partial recanalisation in 25% with the standardized SK scheme; a complete recanalisation could be achieved in 46%, and a partial recanalisation in 30% with the standardized UK scheme.Since April 1, 1985 we use the ultra high SK dosage scheme, with an initial dose of 250.000 IU SK/h and a maintenance dose of 1.500.000 IU SK/h over.6 hours. So far 28 patients were treated in this way. The results show, that with an ultra high SK-dosage scheme a complete recanalisation could be achieved in 46% and a partial recanalisation in 25% in 1-6 day old deep vein thromboses. The results of both the SK schemes and the UK scheme are discussed in accordance with the haemostaseologica1 parameters.

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Deep vein thrombosis"

1

Cheng, Fangqun, Biyun Ye, Ying Tang, et al. Risk factors for deep vein thrombosis in patients with cerebral hemorrhage: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.3.0068.

Full text

Abstract:

Review question / Objective: To identify the risk factors of deep venous thrombosis in patients with cerebral hemorrhage. Eligibility criteria: Inclusion criteria: ①Comply with the “Guidelines for diagnosis of cerebral hemorrhage in China”[7] or “Guidelines for the management of spontaneous intracerebral hemorrhage in the United States”[37], or be diagnosed as ICH in combination with brain CT, MRI, and cerebral angiography; ②Age ≥18 years old; ③Ultrasonography or color polygraph Pler ultrasonography confirmed DVT; ④ The study type was cohort study or case-control study; ⑤ Newcastle-Ottawa Scale (NOS) [8] score ≥ 6 points; ⑥ The language was limited to Chinese and English. Exclusion criteria: ① Repeated publications; ② Studies without full text, incomplete information, or data extraction impossible.

APA, Harvard, Vancouver, ISO, and other styles

2

Gong, Wei, Yongqi Li, Yu Tian, Jing Zhang, and Lei Li. Effects of cardiovascular disease and traditional cardiovascular risk factors on deep vein thrombosis in stroke patients: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.9.0016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Purba, Abdul, Saraswati Gumilang, Dhihintia Jiwangga, Nurina Hasanatuludhhiyah, and Maarten Postma. Cost and clinical outcomes in the use of new oral anticoagulants versus warfarin in deep vein thrombosis: A systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0106.

Full text

Abstract:

Review question / Objective: What are the benefits of using new oral anticoagulants compared to warfarin in terms of efficacy, bleeding, and cost among people with deep vein thrombosis? This study aimed to compare the effectiveness, bleeding incidence, and cost between NOAC and warfarin in DVT patients. Condition being studied: The patient confirmed DVT with the results of the Wells' score and D-dimer test stating "possible DVT" and followed by an ultrasound examination which stated "DVT positive". Patients are taking oral anticoagulants to treat DVT or to prevent a recurrence. Oral anticoagulants consist of apixaban, rivaroxaban, edoxaban, dabigatran, and warfarin.

APA, Harvard, Vancouver, ISO, and other styles

4

hou, xianbing, dandan chen, tongfei cheng, et al. Bleeding risk of anticoagulant therapy in patients with advanced cancer in palliative care settings：a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.4.0064.

Full text

Abstract:

Review question / Objective: The systematic review aim to provide synthesised and appraised evidence to assess the bleeding risk of anticoagulant therapy in patients with advanced cancer in palliative care settings. Condition being studied: Cancer is a recognized risk factor for venous thromboembolism (VTE). The main forms of thromboembolic disease include pulmonary embolism (PE) and deep vein thrombosis (DVT). Given their diagnosis and often poor physical status, patients with advanced cancer are at particularly high risk of developing VTE, resulting in reduced activity levels or even immobility. The exact incidence and prevalence of VTE in the population of cancer patients receiving hospice or palliative care has not been well investigated and few reports are available. Clinical studies have not yet determined whether such patients benefit from anticoagulant therapy and whether there is an increased risk of bleeding and death.

APA, Harvard, Vancouver, ISO, and other styles

5

Saldanha, Ian J., Wangnan Cao, Justin M. Broyles, et al. Breast Reconstruction After Mastectomy: A Systematic Review and Meta-Analysis. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepccer245.

Full text

Abstract:

Objectives. This systematic review evaluates breast reconstruction options for women after mastectomy for breast cancer (or breast cancer prophylaxis). We addressed six Key Questions (KQs): (1) implant-based reconstruction (IBR) versus autologous reconstruction (AR), (2) timing of IBR and AR in relation to chemotherapy and radiation therapy, (3) comparisons of implant materials, (4) comparisons of anatomic planes for IBR, (5) use versus nonuse of human acellular dermal matrices (ADMs) during IBR, and (6) comparisons of AR flap types. Data sources and review methods. We searched Medline®, Embase®, Cochrane CENTRAL, CINAHL®, and ClinicalTrials.gov from inception to March 23, 2021, to identify comparative and single group studies. We extracted study data into the Systematic Review Data Repository Plus (SRDR+). We assessed the risk of bias and evaluated the strength of evidence (SoE) using standard methods. The protocol was registered in PROSPERO (registration number CRD42020193183). Results. We found 8 randomized controlled trials, 83 nonrandomized comparative studies, and 69 single group studies. Risk of bias was moderate to high for most studies. KQ1: Compared with IBR, AR is probably associated with clinically better patient satisfaction with breasts and sexual well-being but comparable general quality of life and psychosocial well-being (moderate SoE, all outcomes). AR probably poses a greater risk of deep vein thrombosis or pulmonary embolism (moderate SoE), but IBR probably poses a greater risk of reconstructive failure in the long term (1.5 to 4 years) (moderate SoE) and may pose a greater risk of breast seroma (low SoE). KQ 2: Conducting IBR either before or after radiation therapy may result in comparable physical well-being, psychosocial well-being, sexual well-being, and patient satisfaction with breasts (all low SoE), and probably results in comparable risks of implant failure/loss or need for explant surgery (moderate SoE). We found no evidence addressing timing of IBR or AR in relation to chemotherapy or timing of AR in relation to radiation therapy. KQ 3: Silicone and saline implants may result in clinically comparable patient satisfaction with breasts (low SoE). There is insufficient evidence regarding double lumen implants. KQ 4: Whether the implant is placed in the prepectoral or total submuscular plane may not be associated with risk of infections that are not explicitly implant related (low SoE). There is insufficient evidence addressing the comparisons between prepectoral and partial submuscular and between partial and total submuscular planes. KQ 5: The evidence is inconsistent regarding whether human ADM use during IBR impacts physical well-being, psychosocial well-being, or satisfaction with breasts. However, ADM use probably increases the risk of implant failure/loss or need for explant surgery (moderate SoE) and may increase the risk of infections not explicitly implant related (low SoE). Whether or not ADM is used probably is associated with comparable risks of seroma and unplanned repeat surgeries for revision (moderate SoE for both), and possibly necrosis (low SoE). KQ 6: AR with either transverse rectus abdominis (TRAM) or deep inferior epigastric perforator (DIEP) flaps may result in comparable patient satisfaction with breasts (low SoE), but TRAM flaps probably increase the risk of harms to the area of flap harvest (moderate SoE). AR with either DIEP or latissimus dorsi flaps may result in comparable patient satisfaction with breasts (low SoE), but there is insufficient evidence regarding thromboembolic events and no evidence regarding other surgical complications. Conclusion. Evidence regarding surgical breast reconstruction options is largely insufficient or of only low or moderate SoE. New high-quality research is needed, especially for timing of IBR and AR in relation to chemotherapy and radiation therapy, for comparisons of implant materials, and for comparisons of anatomic planes of implant placement.

APA, Harvard, Vancouver, ISO, and other styles

6

Thrombolysis may reduce complications of deep vein thrombosis. National Institute for Health Research, 2017. http://dx.doi.org/10.3310/signal-000409.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

New drugs for deep vein thrombosis may offer a safe alternative to warfarin. National Institute for Health Research, 2015. http://dx.doi.org/10.3310/signal-000137.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!